Navigation Links
Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
Date:8/12/2009

CHAPEL HILL, N.C., Aug. 12 /PRNewswire/ -- Cempra Pharmaceuticals today announced the appointment of John H. Johnson, Chief Executive Officer of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to the company's Board of Directors. Mr. Johnson brings more than 25 years of biopharmaceutical executive and operational management experience, including leadership of successful anti-infective businesses and numerous flagship pharmaceutical products, to his role as an independent member of the Board.

"I've been closely tied to the antibacterial and public health product markets throughout my career in the biopharmaceutical industry, and Cempra's clinical-stage anti-infective programs address an absolutely critical market need for safe, potent antibiotics," said Mr. Johnson. "Cempra is at a turning point in the company's development of its two lead compounds, as both are poised to advance into later stage clinical trials. I look forward to working with Cempra's other Board members and management to enable the success of these much-needed drugs."

Cempra's lead macrolide, CEM-101, will soon enter a Phase 2 clinical trial for moderate to moderately severe community-acquired bacterial pneumonia. Cempra has also initiated an adaptive design Phase 2/3 trial in acute bacterial skin structure infections for CEM-102, an antibiotic with an established record of treating staphylococcal infections, including methicillin-resistant Staphylococcus aureus (MRSA). Cempra recently completed a $46 million Series C financing that will fund the further development of these compounds.

"John's respected reputation, deep knowledge of the antibacterial market and strong business acumen makes him an extremely well-positioned, highly-valued addition to our Board of Directors," said Prabhavathi Fernandes, President and CEO, Cempra Pharmaceuticals. "Following a ve
'/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
3. OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
4. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
5. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
6. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
7. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
8. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
9. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. ADVENTRX Pharmaceuticals Announces Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 The advanced optical methods ... that are driving a revolution in the neurosciences were ... journal published by SPIE, the international society for ... with the launch of the BRAIN Initiative in the ... lay out a vision for and provide examples of ...
(Date:7/29/2014)... (July 29, 2014) Tough, ultralight foam of atom-thick ... through a chemical process invented at Rice University. ... like a nanoscale building, with floors and walls that ... of two-dimensional materials: floors and walls of graphene oxide ... platelets. , The researchers say the foam could ...
(Date:7/29/2014)... generation biofuels are a viable solution to the dilemma of ... is very cheap, this is affecting the biofuels market in ... could be in comparison to natural gas. This, in ... for renewable energy developers to get the economics to work ... certain companies have shifted their focused within renewable energy. ...
(Date:7/29/2014)... , July 29, 2014 A ... equipment market (types, applications and geography) - Size, Share, ... Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that ... $12.1 billion by 2020 registering a CAGR of 11.1% ... breakthrough achieved by the electro surgical devices in operative ...
Breaking Biology Technology:SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4Tough foam from tiny sheets 2Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3
... DIEGO, Dec. 9 BioMed Realty Trust, Inc. (NYSE: ... of the previously announced cash tender offer by its operating ... outstanding 4.50% Exchangeable Senior Notes due 2026 (the "Notes"). , ... 8, 2009, the scheduled expiration date of the tender offer, ...
... ... of its Brazilian regional office , ... Chicago, Ill. (Vocus) December 9, 2009 -- As part of ongoing ... Group, a world leader in the contaminated soil , sediment and groundwater ...
... , NEWTON, Mass., Dec. 8 ... announced that James N. Little, Ph.D., has informed the ... Directors effective December 31, 2009. Dr. Little has served ... appointed chairman on December 13, 2007. , (Logo: ...
Cached Biology Technology:BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 2Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 3
(Date:7/29/2014)... researchers sometimes need to get back to basics. ... to study the impacts of the bumphead parrotfish ... at two remote locations in the central Pacific ... computer simulation, McCauley, an assistant professor in the ... his colleagues sought to understand whether the world,s ...
(Date:7/29/2014)... recover from the debilitating effects of a stroke ... knowledge of neurophysiology as well as effective therapy. ... outcomes has been the primary focus of research ... since he joined the NJIT faculty more than ... is underscored by substantial funding from sources such ...
(Date:7/29/2014)... The University of Maryland Schools of Dentistry (UM ... that they have received a five-year $10.7 million ... and Infectious Diseases (NIAID) of the National Institutes ... treatment of sexually-transmitted diseases (STDs). The grant, which ... program, represents a new direction for the research ...
Breaking Biology News(10 mins):Underwater elephants 2Underwater elephants 3Continuing the quest for better stroke therapies 2Continuing the quest for better stroke therapies 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4
... Water runoff from cropped farm fields can contain ... of the fertilizer and herbicide. Expanding on existing conservation ... filters socks in grassed waterways would reduce sediment flow ... reduced sediment in a non-tilled field and reduced concentrations ...
... Institute have found a way to disable a common ... forms of cancer. The researchers discovered, surprisingly, that ... protein, called MCL-1, to make a molecular tool that ... to kill the tumor cells by apoptosis, or programmed ...
... Facility (ALCF), located at the U.S. Department of Energy,s ... processor-hours of computations at a mind-boggling speed of over ... and engineers to conduct cutting-edge research in just weeks ... dedicated to enabling breakthrough science science that will ...
Cached Biology News:Compost filter socks improve runoff from croplands 2Molecular discovery suggests new strategy to fight cancer drug resistance 2Molecular discovery suggests new strategy to fight cancer drug resistance 3Over two billion hours served 2
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Request Info...
Phospho-TAO2 (S181) Affinity Purified Polyclonal Ab Protein Family: Other Intracellular Kinases...
PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....
Biology Products: